(Q34535933)

2 August 2017

title

Dermatomyositis and Polymyositis (English)

1 reference

2 August 2017

0 references

0 references

Hannah R. Briemberg

1

1 reference

2 August 2017

Anthony A. Amato

series ordinal

2

1 reference

2 August 2017

publication date

1 September 2003

1 reference

Current treatment options in neurology

2 August 2017

published in

1 reference

2 August 2017

volume

5

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

349-356

1 reference

Molecular profiles of inflammatory myopathies.

2 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11940-003-0025-9

The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11940-003-0025-9

Azathioprine with prednisone for polymyositis. A controlled, clinical trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11940-003-0025-9

Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients

21 January 2018

1 reference

12 December 2020

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study

1 reference

12 December 2020

Polymyositis and dermatomyositis (first of two parts)

1 reference

12 December 2020

Dermatopolymyositis and other connective tissue diseases: a review of 105 cases

1 reference

12 December 2020

Polymyositis, dermatomyositis and inclusion-body myositis

1 reference

12 December 2020

Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy

1 reference

12 December 2020

Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.

1 reference

12 December 2020

Juvenile dermatomyositis. Pathophysiology and disease expression

1 reference

12 December 2020

Pulmonary disease in polymyositis/dermatomyositis

1 reference

12 December 2020

Electromyographic and histologic paraspinal abnormalities in polymyositis/dermatomyositis

1 reference

12 December 2020

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

1 reference

12 December 2020

Microvascular deposition of complement membrane attack complex in dermatomyositis

1 reference

12 December 2020

Immune manifestations of inflammatory muscle disease

1 reference

12 December 2020

Prednisone and azathioprine for polymyositis: long-term followup.

1 reference

12 December 2020

Dermatomyositis (systemic angiopathy) of childhood

1 reference

12 December 2020

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

1 reference

12 December 2020

Myopathy with antibodies to the signal recognition particle: clinical and pathological features

1 reference

12 December 2020

Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.

1 reference

12 December 2020

Calcification is rare in adult-onset dermatopolymyositis

1 reference

12 December 2020

Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle

1 reference

12 December 2020

Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti-myosin antibody and by blocking complement deposition

1 reference

12 December 2020

Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres

1 reference

12 December 2020

Spontaneous electrical muscle fiber activity in polymyositis and dermatomyositis

1 reference

12 December 2020

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups

1 reference

12 December 2020

Progress in inflammatory myopathies: good but not good enough

1 reference

12 December 2020

Polymyositis and dermatomyositis (second of two parts)

1 reference

12 December 2020

Idiopathic inflammatory myopathies

1 reference

12 December 2020

Relationship of cancer to inflammatory muscle diseases. Dermatomyositis, polymyositis, and inclusion body myositis

1 reference

12 December 2020

Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.

1 reference

12 December 2020

Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature

1 reference

12 December 2020

10.1007/S11940-003-0025-9

Identifiers

DOI

1 reference

2 August 2017

1 reference